This page is solely managed by the hospital for all communications.

Dr. Mouhamed Mounier Alwaw

Gastric Balloon Insertion

14 Yrs

Free Call - Call hospitals worldwide for free using the internet

Zulekha Hospital Sharjah

Sharjah, United Arab Emirates

1992

Founded

7

Doctors

185

Beds

Contact Information

Al Zahra Street Al Nasserya - Al Sharq - Sharjah - United Arab Emirates

About

QUALIFICATIONS AND SPECIAL CLINICAL TRAINING OF DR. MOUHAMED MOUNIER ALWAW Dr. Mouhamed Mounier Alwaw is a Specialist Gastroenterologist working at Zulekha Hospital Sharjah. After finishing his Medicine and acquiring his medical degree, he did his Masters in Gastroenterology and AFS in Hepatogastroenterology from Paris, France. Since then, he has been working as a gastroenterologist and has more than 12 years of experience in the field of Gastroenterology. After completing his master's and AFS in Hepatogastroenterology, he joined Al Kindi Hospital in Homs in western Syria, where he was the Head of the Endoscopy Department. While at Al Kindi Hospital, he was also responsible for organizing regular courses for training the new Gastroenterologists. Dr. Mouhamed Mounier Alwaw was also associated with Al Fayhaa Hospital in Damascus, Syria. He later joined the Zulekha Healthcare Group SPECIAL CLINICAL INTERESTS OF DR. MOUHAMED MOUNIER ALWAW Dr. Mouhamed Mounier Alwaw has a special clinical interest in Gastric Balloon Insertion for the treatment of obesity. He is also interested in different endoscopic procedures such as early detection of colon cancer and treatment of biliary and pancreatic tract illnesses. In addition, he has expertise in biliary stones extraction, stricture dilatation, tumor detection, and stenting with the use of the endoscope. Dr. Mouhamed Mounier Alwaw is fluent in English, Arabic, and French. He has membership with FSGE and SSGE. He also has multiple publications in Syrian Endoscopic Magazine and Arabic Medical Magazine and has an immense interest in research and has conducted various research programs concerning decreasing post ERCP complications and celiac disease, and colon cancer.